Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Pancreas Induction Study
NL-OMON28922Active, not recruiting
- Sponsor
- Roche
- Start
- Oct 1999
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial in organ allograft rejection comparing Zenapax induction with ATG-Fresenius induction (2 arms). Started Oct 1999; status: active, not recruiting.
02
Drugs
daclizumabantithymocyte globulin rabbit
03
Conditions
organ allograft rejection
Beyond the preview
Go deeper on NL-OMON28922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28922.